Plandai Biotechnology Inc (PLPL)

[Aston Martin]

Calculated optimism is left when nothing is left. My judgement bases on the fact that Plandai keeps going on to reduce releases since last year - obvioulsy there ist nothing to release and - fortunately they do not lie in this case. But Plandai has not been able to deliver aynthing yet after going public 2.5 years ago - and I undersatnd why: They have not been able to make pythofare working also before the public going. So they try it all while they are listed. Of course also other biotech companies develop products while they are listed - but it takes sometimes decades until they are able to deliver ( and, not to forget: Plandai does not have such thrilling products). Meanwhile dilution increases and shareholder decreased. I studied the past of Plandai a lot last weeks and I do not like many things which opened my eyes more and more. Plandai is a money machine for Duffield & Co. and this makes this story fishy more and more - especially after this announcement of enormous salaries for directors - even the stock runs on loans only. Smells very bitter for shareholder.

Bounce? Yes! Longterm success? Questionable? Why? This management tastes bad - I would not wonder about endless delays, missing partners and tiny revenues midterm. Ok, just IMO